[HTML][HTML] Drug repurposing to identify a synergistic high-order drug combination to treat sunitinib-resistant renal cell carcinoma
Simple Summary In this study, drug combination screening was used to design a multidrug
combination consisting of repurposed drugs to treat sunitinib-resistant clear cell renal cell …
combination consisting of repurposed drugs to treat sunitinib-resistant clear cell renal cell …
Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
M Rausch, A Rutz, PM Allard, C Delucinge-Vivier… - …, 2021 - infoscience.epfl.ch
Abstract Simple Summary In this study, drug combination screening was used to design a
multidrug combination consisting of repurposed drugs to treat sunitinib-resistant clear cell …
multidrug combination consisting of repurposed drugs to treat sunitinib-resistant clear cell …
Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma.
M Rausch, A Rutz, PM Allard, C Delucinge-Vivier… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: In this study, drug combination screening was used to design a
multidrug combination consisting of repurposed drugs to treat sunitinib-resistant clear cell …
multidrug combination consisting of repurposed drugs to treat sunitinib-resistant clear cell …
Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
M Rausch, A Rutz, PM Allard… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Repurposed drugs have been evaluated for the management of clear cell renal cell
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
[PDF][PDF] Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma. Cancers 2021, 13, 3978
M Rausch, A Rutz, PM Allard, C Delucinge-Vivier… - 2021 - pdfs.semanticscholar.org
Repurposed drugs have been evaluated for the management of clear cell renal cell
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
[PDF][PDF] Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma. Cancers 2021, 13, 3978
M Rausch, A Rutz, PM Allard, C Delucinge-Vivier… - 2021 - serval.unil.ch
Repurposed drugs have been evaluated for the management of clear cell renal cell
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma.
M Rausch, A Rutz, PM Allard, C Delucinge-Vivier… - Cancers, 2021 - europepmc.org
Repurposed drugs have been evaluated for the management of clear cell renal cell
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
[HTML][HTML] Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
M Rausch, A Rutz, PM Allard, C Delucinge-Vivier… - Cancers, 2021 - ncbi.nlm.nih.gov
Repurposed drugs have been evaluated for the management of clear cell renal cell
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
M Rausch, A Rutz, PM Allard, C Delucinge-Vivier… - …, 2021 - search.proquest.com
Repurposed drugs have been evaluated for the management of clear cell renal cell
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
[PDF][PDF] Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma. Cancers 2021, 13, 3978
M Rausch, A Rutz, PM Allard, C Delucinge-Vivier… - 2021 - access.archive-ouverte.unige.ch
Repurposed drugs have been evaluated for the management of clear cell renal cell
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …
carcinoma (ccRCC), but only a few have influenced the overall survival of patients with …